RBL LLC welcomes Devyn Smith to board of directors
HOUSTON, April 22, 2025 /PRNewswire/ -- RBL LLC, a pioneering biotech venture creation studio dedicated to rapidly building companies based on breakthrough medical technologies from Rice University, announced the appointment of Devyn Smith to its board of directors. Smith, a distinguished biopharmaceutical executive and current CEO of Arbor Biotechnologies, brings extensive experience in regenerative medicine, company formation and commercial strategy that will be instrumental in RBL's mission to accelerate lifesaving therapies from bench to bedside.